These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14501)

  • 1. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of pindolol in hypertensive patients.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand Suppl; 1977; 606():55-62. PubMed ID: 268933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1977; 202(6):517-21. PubMed ID: 339674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    Am Heart J; 1986 Aug; 112(2):368-74. PubMed ID: 2874735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
    Fitscha P; Meisner W; Brandstetter G; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    Dvorák I; Blaha M; Nĕmcová H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Golightly LK
    Pharmacotherapy; 1982; 2(3):134-47. PubMed ID: 6133267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
    Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
    Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal beta-blocker therapy in essential hypertension.
    Spieker C; Vetter H; Liedtke R; Zidek W; Vetter W
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):199S-200S. PubMed ID: 2901265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.